HWAIL PHARM. CO., LTD Logo

HWAIL PHARM. CO., LTD

Develops and manufactures Active Pharmaceutical Ingredients and finished drug formulations.

061250 | KO

Overview

Corporate Details

ISIN(s):
KR7061250007
LEI:
Country:
South Korea
Address:
경기도 화성시 향남읍 제약공단3길 57, 화성시

Description

Hwail Pharm. Co., Ltd. is a pharmaceutical company that specializes in the research, development, manufacturing, and distribution of Active Pharmaceutical Ingredients (APIs). The company also provides a range of finished drug formulations, including generic and patented medications, as well as functional health products. A core focus of the organization is maintaining high standards through continuous R&D investment and rigorous quality control processes to develop and produce its pharmaceutical products.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-07-02 00:00
주식등의대량보유상황보고서(일반)
Korean 92.8 KB
2025-07-02 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.2 KB
2025-07-01 00:00
최대주주변경
Korean 30.3 KB
2025-07-01 00:00
주식등의대량보유상황보고서(일반)
Korean 106.2 KB
2025-07-01 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.2 KB
2025-06-19 00:00
주식등의대량보유상황보고서(일반)
Korean 105.9 KB
2025-06-16 00:00
전환청구권행사
Korean 11.7 KB
2025-06-13 00:00
주주총회소집결의 (임시주주총회)
Korean 6.2 KB
2025-06-13 00:00
주주명부폐쇄기간또는기준일설정
Korean 4.5 KB
2025-06-11 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.3 KB
2025-06-11 00:00
최대주주변경을수반하는주식양수도계약체결
Korean 20.1 KB
2025-06-11 00:00
임원ㆍ주요주주특정증권등거래계획보고서
Korean 41.7 KB
2025-06-11 00:00
주식등의대량보유상황보고서(일반)
Korean 104.3 KB
2025-05-14 00:00
분기보고서 (2025.03)
Korean 1.1 MB
2025-04-18 00:00
전환가액의조정
Korean 12.7 KB

Automate Your Workflow. Get a real-time feed of all HWAIL PHARM. CO., LTD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for HWAIL PHARM. CO., LTD

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for HWAIL PHARM. CO., LTD via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.